💨 Abstract

The FDA has expanded the approval of Addyi, a drug for low female libido, to include women over 65 who have gone through menopause. Initially approved in 2015 for premenopausal women, Addyi has faced challenges due to side effects and safety warnings, particularly regarding alcohol consumption. The drug's approval followed a lobbying campaign highlighting the lack of options for female sexual dysfunction.

Courtesy: WTOP Staff